{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:50:34Z","timestamp":1785426634857,"version":"3.56.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National University Ireland, Galway"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Triple Assessment Breast Clinics are designed for rapid diagnosis of symptomatic patients. When there is no concordance between clinical and radiological assessment, clinicians perform clinical core biopsies. In patients with a clinically suspicious examination (S4, S5) and normal imaging, clinically guided core biopsy should be performed as per NCCP guidelines. However, substantial research does not exist on the diagnostic value or use of clinical core biopsies in non-suspicious palpable (S3) lesions and practices differ in each health system.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Aims<\/jats:title>\n                <jats:p>The aim of this research was to assess the diagnostic value of clinical core biopsies in nonsuspicious, probably benign palpable breast lesions (S3) where image guided cores were not indicated (R1\/R2).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The cohort consisted of patients undergoing clinical core biopsies at a Symptomatic Breast Unit from January 2014 to 2019. Data regarding patient demographics, outcome of triple-assessment and incidence of malignancy were obtained from a prospectively maintained database and results were analysed using Minitab 2018.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Three hundred and sixty patients had a clinical core biopsy performed in this period. Clinical examination scores for these patients were S1\/S2 (66), S3 (277), S4 (15), and S5 (2). Radiology Scores were R1\/R2 (355) and R3(5). Two patients with clinical score S3 (0.6%) were diagnosed with breast cancer due to their clinical cores. Both patients had normal mass imaging. There was no association between uncertain palpable breast lesions (S3), and atypia or malignancy on biopsy results when breast imaging was normal (<jats:italic>P<\/jats:italic>\u2009=\u20090.43, \u03c7<jats:sup>2<\/jats:sup>\u00a0test).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Despite clinical core biopsies being used in triple assessment, there is no certainty in their value except that there is high clinical suspicion. Imaging modalities are constantly improving and are already well established. When the patient is assigned a clinical score of S3 and has normal radiology, a clinical core biopsy is not required in most cases.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11845-023-03445-z","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T03:25:57Z","timestamp":1691465157000},"page":"565-570","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Triple assessment breast clinics: The value of clinical core biopsies"],"prefix":"10.1007","volume":"193","author":[{"given":"Rahmani","family":"Maha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnston","family":"Alison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sugrue","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0288-8827","authenticated-orcid":false,"given":"Varzgalis","family":"Manvydas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,8]]},"reference":[{"key":"3445_CR1","unstructured":"National Cancer Forum (2006) A strategy for cancer control in Ireland, Department of Health & Children.\u00a0https:\/\/www.screeningservice.ie\/publications\/CancerControlStrategy2006.pdf"},{"key":"3445_CR2","unstructured":"National Cancer Control Programme, O\u2019Rourke N (2012) Review of referral patterns and triage processes in symptomatic breast units. A hospital perspective.\u00a0https:\/\/www.lenus.ie\/bitstream\/handle\/10147\/213014\/ReviewReferralPattterns.pdf?sequence=1&isAllowed=y"},{"key":"3445_CR3","unstructured":"National Cancer Control Programme (2013) Report for 2011 on the symptomatic breast disease key performance indicators.\u00a0https:\/\/www.hse.ie\/eng\/services\/list\/5\/cancer\/pubs\/intelligence\/kpisbd2011.pdf"},{"key":"3445_CR4","unstructured":"National Cancer Control Programme (2021) National Breast Cancer GP Referral Guidelines.\u00a0https:\/\/www.hse.ie\/eng\/services\/list\/5\/cancer\/profinfo\/resources\/gpreferrals\/national-breast-cancer-gp-referral-guideline.pdf"},{"key":"3445_CR5","unstructured":"Willett AM, Michell MJ, Lee MJ (2010) Best practice diagnostic guidelines for patients presenting with breast symptoms. London: Department of Health.\u00a0https:\/\/www.tasmiabreastcare.co.uk\/dynamicdata\/image\/baso%20best%20practice%20guidelines.pdf"},{"key":"3445_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2011.10.010","author":"H Gumus","year":"2011","unstructured":"Gumus H, Gumus M, Mills P et al (2011) Clinically palpable breast abnormalities with normal imaging: is clinically guided biopsy still required? Clin Radiol. https:\/\/doi.org\/10.1016\/j.crad.2011.10.010","journal-title":"Clin Radiol"},{"key":"3445_CR7","unstructured":"Ellis IO (2005) Pathology reporting of breast disease: A joint document incorporating the third edition of the NHS Breast Screening Programme\u2019s guidelines for pathology reporting in breast cancer screening and the second edition of the Royal College of Pathologists\u2019 minimum dataset for breast cancer histopathology. Sheffield: NHS Cancer Screening Programmes.\u00a0https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/541521\/pathology_reporting_of_breast_disease.pdf"},{"key":"3445_CR8","doi-asserted-by":"crossref","unstructured":"Pluchinotta, A.M. (2015) The Outpatient Breast Clinic aiming at best practice. Cham, Switzerland: Springer.","DOI":"10.1007\/978-3-319-15907-2"},{"key":"3445_CR9","unstructured":"National Cancer Control Programme (2015) Diagnosis, staging and treatment of patients with breast cancer National Clinical Guideline No. 7"},{"key":"3445_CR10","doi-asserted-by":"publisher","unstructured":"Alameer A, Common M, Elwahab SA et al (2022) Clinically guided core biopsy and cutaneous punch biopsy in the evaluation of breast lesions: a necessary test or an obsolete skill? Irish J Med Sci (1971) 192:317\u2013319.\u00a0https:\/\/doi.org\/10.1007\/s11845-022-02937-8","DOI":"10.1007\/s11845-022-02937-8"},{"key":"3445_CR11","unstructured":"Irish Cancer Society (2022) Available online at: https:\/\/www.cancer.ie\/cancer-information-and-support\/cancer-types\/breast-cancer"},{"key":"3445_CR12","unstructured":"Breast Cancer Ireland (2022) Available online at: https:\/\/www.breastcancerireland.com\/"},{"key":"3445_CR13","doi-asserted-by":"publisher","DOI":"10.4103\/0971-5916.187108","author":"S Hari","year":"2016","unstructured":"Hari S, Kumari S, Srivastava A (2016) Image guided versus palpation guided core needle biopsy of palpable breast masses: a prospective study. Indian J Med Res. https:\/\/doi.org\/10.4103\/0971-5916.187108","journal-title":"Indian J Med Res"},{"key":"3445_CR14","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.54.6.345","author":"S McDonald","year":"2004","unstructured":"McDonald S, Saslow D, Alciati MH (2004) Performance and reporting of clinical breast examination: A review of the literature. CA Cancer J Clin. https:\/\/doi.org\/10.3322\/canjclin.54.6.345","journal-title":"CA Cancer J Clin"},{"key":"3445_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.12.971","author":"JK Bobo","year":"2000","unstructured":"Bobo JK, Lee NC, Thames SF (2000) Findings from 752,081 clinical breast examinations reported to a national screening program from 1995 through 1998. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/92.12.971","journal-title":"J Natl Cancer Inst"},{"key":"3445_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07521-w","author":"TT Ngan","year":"2020","unstructured":"Ngan TT, Nguyen NT, Van Minh H et al (2020) Effectiveness of clinical breast examination as a \u2018stand-alone\u2019 screening modality: an overview of systematic reviews. BMC Cancer. https:\/\/doi.org\/10.1186\/s12885-020-07521-w","journal-title":"BMC Cancer"},{"key":"3445_CR17","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000002024","author":"S Laufer","year":"2017","unstructured":"Laufer S, D\u2019Angelo AD, Kwan C et al (2017) Rescuing the clinical breast examination: advances in classifying technique and assessing physician competency. Ann Surg. https:\/\/doi.org\/10.1097\/SLA.0000000000002024","journal-title":"Ann Surg"},{"key":"3445_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacr.2017.02.033","author":"L Moy","year":"2017","unstructured":"Moy L, Heller SL, Bailey L et al (2017) ACR appropriateness criteria palpable breast masses J Am Coll Radiol. https:\/\/doi.org\/10.1016\/j.jacr.2017.02.033","journal-title":"ACR appropriateness criteria palpable breast masses J Am Coll Radiol"},{"key":"3445_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2009.01.010","author":"AJ Maxwell","year":"2009","unstructured":"Maxwell AJ, Ridley NT, Rubin G et al (2009) The Royal College of Radiologists Breast Group breast imaging classification. Clin Radiol. https:\/\/doi.org\/10.1016\/j.crad.2009.01.010","journal-title":"Clin Radiol"},{"key":"3445_CR20","unstructured":"Joy JE, Penhoet EE, Petitti DB (2005) Saving women\u2019s lives: Strategies for improving breast cancer detection and diagnosis. Washington, DC: National Academies Press. Available at https:\/\/nap.nationalacademies.org\/read\/11016\/chapter\/1"},{"key":"3445_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-016-4636-4","author":"S Weigel","year":"2017","unstructured":"Weigel S, Heindel W, Heidrich J et al (2017) Digital mammography screening: sensitivity of the programme dependent on breast density. Eur Radiol. https:\/\/doi.org\/10.1007\/s00330-016-4636-4","journal-title":"Eur Radiol"},{"key":"3445_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/tbj.14199","author":"JC Neal","year":"2021","unstructured":"Neal JC, Saith S, Khong-McBride C et al (2021) Does diagnostic mammography need to be a routine component of the initial evaluation of a breast symptom in women 30\u201339 years of age? Breast J. https:\/\/doi.org\/10.1111\/tbj.14199","journal-title":"Breast J"},{"key":"3445_CR23","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.12.8842","author":"CD Lehman","year":"2012","unstructured":"Lehman CD, Lee CI, Loving VA et al (2012) Accuracy and value of breast ultrasound for primary imaging evaluation of symptomatic women 30\u201339 years of age. Am J Roentgenol. https:\/\/doi.org\/10.2214\/AJR.12.8842","journal-title":"Am J Roentgenol"},{"key":"3445_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacr.2017.08.044","author":"MB Mainiero","year":"2013","unstructured":"Mainiero MB, Lourenco A, Mahoney MC et al (2013) ACR appropriateness criteria breast cancer screening. J Am Coll Radiol. https:\/\/doi.org\/10.1016\/j.jacr.2017.08.044","journal-title":"J Am Coll Radiol"},{"key":"3445_CR25","doi-asserted-by":"publisher","DOI":"10.1200\/JGO.19.00127","author":"R Sood","year":"2019","unstructured":"Sood R, Rositch AF, Shakoor D et al (2019) Ultrasound for breast cancer detection globally: a systematic review and meta-analysis. J Glob Oncol. https:\/\/doi.org\/10.1200\/JGO.19.00127","journal-title":"J Glob Oncol"},{"key":"3445_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-016-1472-0","author":"CE Redmond","year":"2017","unstructured":"Redmond CE, Healy GM, Murphy CF et al (2017) The use of ultrasonography and digital mammography in women under 40 years with symptomatic breast cancer: a 7-year Irish experience. Ir J Med Sci. https:\/\/doi.org\/10.1007\/s11845-016-1472-0","journal-title":"Ir J Med Sci"},{"key":"3445_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-018-1794-1","author":"RM O\u2019Cearbhaill","year":"2019","unstructured":"O\u2019Cearbhaill RM, Hembrecht S, Devane LA et al (2019) Breast screening in symptomatic women over 35 years of age: improvements in service efficiency. Ir J Med Sci. https:\/\/doi.org\/10.1007\/s11845-018-1794-1","journal-title":"Ir J Med Sci"},{"key":"3445_CR28","doi-asserted-by":"publisher","DOI":"10.1259\/bjr\/32906819","author":"P Britton","year":"2012","unstructured":"Britton P, Warwick J, Wallis MG et al (2012) Measuring the accuracy of diagnostic imaging in symptomatic breast patients: team and individual performance. Br J Radiol. https:\/\/doi.org\/10.1259\/bjr\/32906819","journal-title":"Br J Radiol"},{"key":"3445_CR29","doi-asserted-by":"publisher","unstructured":"Flobbe K, Nelemans PJ, Kessels AG et al (2002) The role of ultrasonography as an adjunct to mammography in the detection of breast cancer. A systematic review. Eur J Cancer. https:\/\/doi.org\/10.1016\/s0959-8049(01)00388-4","DOI":"10.1016\/s0959-8049(01)00388-4"},{"key":"3445_CR30","doi-asserted-by":"publisher","unstructured":"Sinha NK, Kumari N (2020) A study to evaluate the relevance and validity of triple assessment in diagnosing carcinoma breast. J Evol Med Dent Sci. https:\/\/doi.org\/10.14260\/jemds\/2020\/301","DOI":"10.14260\/jemds\/2020\/301"},{"key":"3445_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/bcr513","author":"A O'Connor","year":"2002","unstructured":"O\u2019Connor A, Wylie E, Nuttall L (2002) Complications of breast core biopsy. Breast Cancer Res. https:\/\/doi.org\/10.1186\/bcr513","journal-title":"Breast Cancer Res"},{"key":"3445_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2009.12.003","author":"ST Ward","year":"2010","unstructured":"Ward ST, Shepherd JA, Khalil H (2010) Freehand versus ultrasound-guided core biopsies of the breast: reducing the burden of repeat biopsies in patients presenting to the breast clinic. The Breast. https:\/\/doi.org\/10.1016\/j.breast.2009.12.003","journal-title":"The Breast"},{"key":"3445_CR33","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000186186.05971.e0","author":"MF Dillon","year":"2005","unstructured":"Dillon MF, Hill AD, Quinn CM et al (2005) The accuracy of ultrasound, stereotactic, and clinical core biopsies in the diagnosis of breast cancer, with an analysis of false-negative cases. Ann Surg. https:\/\/doi.org\/10.1097\/01.sla.0000186186.05971.e0","journal-title":"Ann Surg"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-023-03445-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-023-03445-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-023-03445-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T03:56:26Z","timestamp":1711338986000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-023-03445-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,8]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["3445"],"URL":"https:\/\/doi.org\/10.1007\/s11845-023-03445-z","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,8]]},"assertion":[{"value":"24 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}